NVIDIA shares set for rebound after breaking $200

Since peaking at $236.16 in May, NVIDIA shares have been in a tailspin, hitting a session low of $199.63 on June 23 and breaching the key psychological threshold of $200. The speed and depth of this plunge set the stage for a rebound, as markets tend to react to violent impulse moves with a snapback rather than a relentless slide.

Still, moving averages are flashing warning signs. The stock is currently trading below both the EMA (20) at $208.79 and the EMA (50) at $206.30, with two lines converging dangerously—a setup that could soon produce a "death cross" if the price stays pinned beneath them.

The main argument for an upward correction, however, lies with the Relative Strength Index (RSI). The indicator is hovering just above oversold territory—a clear sign that the decline has gone too far, too fast, and a breather is overdue. What's more, the rising Average True Range (ATR) adds weight to this view: volatility has shifted from a contraction phase to active expansion, and when that happens in depressed conditions, it often precedes a sharp counter-move, as bears run out of steam and bulls step back in.

But here is the kicker: the June 23rd slide wasn't about NVIDIA; it was collateral damage from a broader semiconductor rout triggered by SK Hynix's HBM4 production slowdown. The good news? The company's fundamentals remain rock solid: second-quarter revenue guidance stands at $91 billion (excluding China), and hyperscalers have committed $119 billion. On top of that, the Asian risk has already been baked into forecasts. Meanwhile, the BioNeMo Agent Toolkit launch is opening doors to the pharmaceutical and scientific sectors. This gap between technical panic and steady fundamentals makes the current level a compelling entry point.

For those ready to act, pay attention to the trading plan down below:

Buy NVIDIA shares on a rebound from the $199–$200 range. Place Take Profit at $211. Set Stop Loss at $193.

This forecast holds true from June 24 till July 1, 2026.